FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
-14%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$627M
AUM Growth
+$627M
(+1.2%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
18%
Top 10 Holdings %
Top 10 Hldgs %
49.49%
Holding
67
New
8
Increased
17
Reduced
20
Closed
8
Top Buys
Top Sells
| 1 |
NeoGenomics
NEO
|
$18.8M |
| 2 |
SHPG
Shire pic
SHPG
|
$11.4M |
| 3 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$7.93M |
| 4 |
Sangamo Therapeutics
SGMO
|
$4.51M |
| 5 |
Dynavax Technologies
DVAX
|
$1.84M |
Sector Composition
| 1 | Healthcare | 77.01% |
| 2 | Communication Services | 3.64% |
| 3 | Energy | 0.8% |
| 4 | Financials | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $40.7M | 6.48% | 2,853,826 +472,680 | +20% | +$6.74M |
|
2
Omnicell
OMCL
$1.5B
| $40.5M | 6.45% | 660,655 -2,454 | -0.4% | -$150K |
|
|
SPNE
3
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $32.6M | 5.19% | +1,785,071 | New | +$32.6M |
|
|
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $32.1M | 5.12% | 2,514,552 +920,543 | +58% | +$11.8M |
|
5
Ionis Pharmaceuticals
IONS
$6.8B
| $31.9M | 5.09% | 590,010 +97,870 | +20% | +$5.29M |
|
6
AtriCure
ATRC
$1.84B
| $29.6M | 4.71% | 965,797 -3,396 | -0.4% | -$104K |
|
|
SHPG
7
DELISTED
Shire pic
SHPG
| $28.4M | 4.53% | 163,409 -65,236 | -29% | -$11.4M |
|
|
8
NeoGenomics
NEO
$1.13B
| $27.8M | 4.44% | 2,208,188 -1,492,739 | -40% | -$18.8M |
|
9
Nektar Therapeutics
NKTR
$568M
| $24M | 3.83% | 730,226 +357,675 | +96% | +$11.8M |
|
|
MODN
10
DELISTED
MODEL N, INC.
MODN
| $22.8M | 3.64% | 1,726,404 +391,805 | +29% | +$5.18M |
|
11
Harvard Bioscience
HBIO
$22M
| $22.3M | 3.55% | 7,009,586 +739,471 | +12% | +$2.35M |
|
12
Heron Therapeutics
HRTX
$207M
| $21.4M | 3.41% | 825,269 -7,732 | -0.9% | -$201K |
|
|
XENT
13
DELISTED
Intersect ENT, Inc
XENT
| $19.8M | 3.15% | 701,398 +184,277 | +36% | +$5.19M |
|
|
IMMU
14
DELISTED
Immunomedics Inc
IMMU
| $19.4M | 3.09% | 1,360,280 +208,658 | +18% | +$2.98M |
|
15
Veracyte
VCYT
$2.39B
| $19.2M | 3.06% | 1,523,405 +335,711 | +28% | +$4.22M |
|
|
NVTR
16
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $19M | 3.03% | 1,162,451 +779,543 | +204% | +$12.7M |
|
17
Codexis
CDXS
$246M
| $17.7M | 2.82% | 1,059,359 +221,811 | +26% | +$3.7M |
|
18
Xencor
XNCR
$580M
| $16.8M | 2.69% | 465,770 -1,883 | -0.4% | -$68.1K |
|
|
CSII
19
DELISTED
Cardiovascular Systems, Inc.
CSII
| $13.7M | 2.19% | 482,104 -2,350 | -0.5% | -$67K |
|
20
Halozyme
HALO
$8.56B
| $13.7M | 2.19% | 938,399 +52,876 | +6% | +$774K |
|
21
Ligand Pharmaceuticals
LGND
$3.15B
| $12.8M | 2.04% | 94,382 +21,362 | +29% | +$2.9M |
|
22
KORU Medical Systems
KRMD
$195M
| $11.3M | 1.8% | +6,848,900 | New | +$11.3M |
|
23
Tandem Diabetes Care
TNDM
$845M
| $10M | 1.6% | 263,883 | – | – |
|
|
KDNY
24
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $9.42M | 1.5% | +3,568,955 | New | +$9.42M |
|
|
VAPO
25
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $6.08M | 0.97% | +304,509 | New | +$6.08M |
|